| Literature DB >> 33363409 |
Yang Zhang1, Fang Yao1, Xiaohong Kuang1, Lijuan Li1, Lihua Huang1, Qi Zhou1, Jiazhu Peng1, Qingyu Chang2.
Abstract
PURPOSE: To evaluate the quality of systematic reviews/meta-analyses (SR/MAs) on alternative exercise traditions in cancer care.Entities:
Keywords: COVID-19; alternative exercise traditions; cancer care; overview
Year: 2020 PMID: 33363409 PMCID: PMC7753005 DOI: 10.2147/CMAR.S282491
Source DB: PubMed Journal: Cancer Manag Res ISSN: 1179-1322 Impact factor: 3.989
Figure 1PubMed search strategy.
Figure 2The PRISMA flow diagram of study inclusion in the review.
Notes: PRISMA figure adapted from Liberati A, Altman D, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Journal of clinical epidemiology. 2009;62(10). Creative Commons.41
Characteristics of Included SR/MAs
| Authors, | Country | Number of Studies/Sample Size | Quality Criteria | Duration | Intervention Group | Control Group | Main | Outcome Results |
|---|---|---|---|---|---|---|---|---|
| Luo et al, | China | 15/885 | Cochrane | 2006–2019 | RRT+8-form TCC; Usual care +8-form TCC; RRT + Chen-style TCC; Usual care +18-form TCC; RRT + 24-form simplified | Usual care; Cognitive behavioral therapy; RRT; Standard support Therapy; Psychosocial support therapy | ①②③ | TCC is effective on quality of life, pain and anxiety in breast cancer patients. |
| Lee et al, | South Korea | 7/235 | Cochrane | 2003– | Tai Chi;Yang style;Combining Yang and Sun style | No treatment; Psychosocial support therapy; Spiritual growth; Standard health Care; Walking; Education Program | ① | Tai Chi is not effective on quality of life for supportive breast cancer care. |
| Pan et al, | China | 19/322 | Cochrane | 2004–2013 | Tai Chi; Yang-style TCC; 8-form TCC | Health education; Psychosocial | ②④ | Tai Chi is not effective on pain and BMI in breast cancer patients. |
| Yan et al, | China | 5/407 | Jadad scale | 2004–2012 | 15-move short-form of Yang-style TCC; 24-form of TCC; 8-move short form of TCC | Psychosocial Therapy; Standard support therapy; Usual care; | ①④ | Tai Chi is not effective on quality of life (except emotional well-being) and BMI in breast cancer patients. |
| Zhang et al, | China | 6/382 | Cochrane | 2007–2012 | Hatha yoga; Restorative yoga; | Wait-list; Nontreatment | ①③⑤⑥⑦ | Yoga is effective on quality of life, but not effective on anxiety, depression, distress and sleep outcome in women with breast cancer |
| Buffart et al, | Netherlands | 13/695 | Not mentioned | 2003– | Integrated yoga program; | Non-exercise; Wait-list | ③⑤⑥⑦⑧ | Yoga is effective on anxiety, depression and distress, but not effective on sleep outcome and fatigue in cancer patients and survivors. |
| Cramer | Germany | 12/742 | Cochrane | 2003–2011 | Iyengar Yoga; Integrated yoga; | Wail-list; Supportive counseling and advice to take light exercise; | ①③⑥ | Yoga is effective on quality of life, and short-term yoga is effective on anxiety and depression in breast cancer patients. |
| Dong et al, | China | 12/2183 | Cochrane | 2009–2018 | Hatha yoga+home-based yoga; Integrated yoga; | Standard care; Supportive counseling; Wait-list | ⑧ | Yoga is effective on fatigue in patients with breast cancer. |
| Ford et al, | USA | 17/666 | NIH Quality Assessment | 2000– | Taichi; Qigong; Yoga | Usual care; Wait-list; Education groups; Attention controls | ① | TaiChi/Qigong and Yoga are effective on quality of life in male cancer survivors. |
| Hashimi | Canada | 8/545 | Not mentioned | 2008–2018 | Vivekananda Yoga Anusandhana Samsthana; Hatha yoga; Anusandhana Samsthana; | Stretching; Standard exercise; | ① | Yoga is not effective on quality of life of women with breast cancer. |
| Harder | UK | 18/164 | PEDro criteria | 2006– | Integrated yoga; Lyengar yoga; Hatha yoga; Restorative yoga; | Supportive therapy; Wait-list; | ① | Yoga may be a useful practice in improving the quality of life of women with breast cancer. |
| Lee | UK | 4/226 | Jadad | 2003–2006 | Tai Chi | Walking exercise; Psychosocial support;Education program | ① | Tai Chi is not effective on quality of life for cancer. |
| Pan | China | 16/930 | Cochrane | 2007–2012 | Integrated yoga;Iyengar yoga; | Supportive therapy; Wait-list; | ①③⑤⑥⑧ | Yoga is effective on sleep outcome,quality of life, |
| Wang | China | 19/1832 | Cochrane | 2009– | Iyengar Yoga; Asanas yoga; | Wait-list; Health education; | ⑤ | Yoga is an effective supportive treatment for cancer in sleep outcome. |
| Sadja | USA | 10/583 | Not mentioned | 2004– | Iyengar yoga; Tibetan yoga; | Wait-list; Health education | ⑧ | Yoga may be beneficial for reducing fatigue in women with breast cancer. |
| Liu | China | 16/1268 | PEDro criteria | 2003– | Tai Chi; Tai Chi+Standard rehabilitation training | Cognitive behavior therapy; | ①④⑤⑥ | Tai Chi is effective on quality of life, but not effective on sleep outcome, BMI, depression and fatigue in breast cancer patients. |
| Espíndula | Brazil | 4/150 | Cochrane | 2010–2016 | Pilates; Pilates+home exercise | Home exercise;No exercise | ②⑧ | Pilates may be beneficial for reducing pain and fatigue of breast cancer patients. |
| Carral | Spain | 4/246 | Cochrane | 2008–2013 | Pilates exercise+home pilates; | Information and drainage and walking exercise;No exercise; | ①② | Pilates has a certain effect on quality of life and pain for women with breast cancer. |
| Zeng | China | 13/592 | Cochrane | 2003–2013 | Taichi; Guolin new qigong; Yang style of taichi; Medical qigong | Health education; Wait-list; | ①③④⑥ | Qigong/Tai Chi are effective on quality of life and anxiety,but not effective on BMI and depression of cancer patients. |
| Wayne | USA | 15/1283 | Cochrane | 2008–2013 | Taichi; Qigong | Psychosocial support; Usual care; | ①②⑤⑥ | Qigong/Tai Chi are effective on sleep outcome, |
| Zeng et al, 2019 | China | 12/915 | Cochrane | 2014–2018 | Taichi; Qigong; Taichi+Qigong; | Usual care; Support groups; | ①③⑤⑧ | Qigong/Tai Chi are effective on sleep outcome and fatigue, but not effective on quality of life,anxiety, |
| Lin et al, | China | 10/788 | PEDro criteria | 2000–2009 | Restorative yoga; Integrated yoga; Gentle yoga; Hatha yoga; Asanas+shevasana; | Wait-list; Support therapy | ③⑥⑦ | Yoga is effective on anxiety, depression and distress of cancer patients. |
| Pan et al, | China | 12/1979 | Cochrane | 2004–2013 | 19-move short-form of TCC; | Rehabilitation nursing; Health education; Psychosocial therapy; | ①②④ | Tai Chi is effective on BMI, but not effective on quality of life and pain of postoperative patients |
| Yan et al, | China | 4/169 | Cochrane | 2003–2010 | Yang-style TCC; Short form of TCC; 24-move short form of TCC | Psychosocial Therapy; Walking; | ①④ | Tai Chi is not effective on quality of life and BMI in breast cancer patients. |
| Zhang | China | 9/623 | Cochrane | 2007–2014 | Anusara yoga; Lyengar yoga; Patanjali’s yoga; Restorative yoga; Hatha yoga; Viniyoga | Usual care; Health education; One-to-one meeting | ⑧ | Yoga is effective on fatigue of breast cancer patients. |
| Wu | China | 7/671 | Cochrane | 2015–2017 | Yoga | Wait-list; Health education; Usual care; Social support | ①③⑤⑥ | Yoga is effective on quality of life, anxiety and depression, but not effective on sleep outcome in patients with breast cancer. |
Notes: TCC, Tai Chi; ①quality of life;②pain;③anxiety;④BMI;⑤sleep outcome; ⑥ depression; ⑦ distress; ⑧ fatigue.
Outcome Results of Included SR/MAs
| Outcome | Authors, Year | Outcome Results | Outcome | Authors, Year | Outcome Results | Outcome | Authors, Year | Outcome Results |
|---|---|---|---|---|---|---|---|---|
| Quality of life | Luo et al, 2020 | * | Pain | Luo et al, 2020 | * | BMI | Pan et al, 2015 | # |
| Lee et al, 2010 | # | Pan et al, 2015 | # | Yan et al, 2014 | # | |||
| Yan et al, 2014 | # | Espíndula et al,2017 | * | Liu et al, 2020 | # | |||
| Zhang et al, 2012 | * | Carral et al, 2018 | * | Zeng et al, 2014 | # | |||
| Cramer et al, 2012 | * | Wayne et al, 2017 | # | Pan et al, 2016 | * | |||
| Ford et al, 2020 | * | Pan et al, 2016 | # | Yan et al, 2013 | # | |||
| Hashimi et al, 2019 | # | Anxiety | Luo et al, 2020 | * | Sleep outcome | Zhang et al, 2012 | # | |
| Harder et al,2012 | * | Zhang et al, 2012 | # | Buffart et al, 2012 | # | |||
| Lee et al, 2007 | # | Buffart et al, 2012 | * | Pan et al, 201527 | * | |||
| Pan et al, 2015 | * | Cramer et al, 2012 | * | Wang et al, 2020 | * | |||
| Liu et al, 2020 | * | Pan et al, 2015 | * | Liu et al, 2020 | # | |||
| Carral et al, 2018 | * | Zeng et al, 2019 | # | Wayne et al, 2017 | * | |||
| Zeng et al, 2014 | * | Lin et al, 2011 | * | Zeng et al, 2019 | * | |||
| Wayne et al, 2017 | * | Wu et al, 2018 | * | Wu et al, 2018 | # | |||
| Zeng et al, 2019 | # | Depression | Zhang et al, 2012 | # | Fatigue | Buffart et al, 2012 | # | |
| Pan et al, 2016 | # | Buffart et al, 2012 | * | Dong et al, 2019 | * | |||
| Yan et al, 2013 | # | Cramer et al, 2012 | * | Pan et al, 2015 | # | |||
| Wu et al,2018 | * | Pan et al, 2015 | * | Sadja et al, 2013 | * | |||
| Distress | Zhang et al, 2012 | # | Liu et al, 2020 | # | Liu et al, 2020 | # | ||
| Buffart et al, 2012 | * | Zeng et al, 2014 | # | Espíndula et al, 2017 | * | |||
| Lin et al, 2011 | * | Wayne et al, 2017 | * | Zeng et al, 2019 | * | |||
| Lin et al, 2011 | * | Zhang et al, 2015 | * | |||||
| Wu et al, 2018 | * |
Note: *, Alternative exercise traditions are useful; #, Alternative exercise traditions are useless.
Quality Assessment of the Included Reviews Using the AMSTAR Tool (n = 26)
| Authors, Year | AMSTAR Items | Total | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Q1 | Q2 | Q3 | Q4 | Q5 | Q6 | Q7 | Q8 | Q9 | Q10 | Q11 | Y | N | C | |
| Luo et al,2020 | Y | Y | Y | N | Y | Y | Y | Y | Y | Y | N | 9 | 2 | 0 |
| Lee et al, 2010 | N | Y | Y | N | Y | Y | Y | Y | Y | N | N | 7 | 4 | 0 |
| Pan et al, 2015 | N | Y | N | N | Y | Y | Y | Y | Y | N | N | 6 | 5 | 0 |
| Yan et al, 2014 | N | N | N | N | Y | Y | Y | Y | Y | Y | N | 6 | 5 | 0 |
| Zhang et al, 2012 | N | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | 10 | 1 | 0 |
| Buffart et al,2012 | N | N | Y | N | Y | Y | Y | Y | Y | Y | Y | 8 | 3 | 0 |
| Cramer et al,2012 | N | Y | N | N | Y | Y | Y | Y | Y | Y | Y | 8 | 3 | 0 |
| Dong et al, 2019 | N | Y | Y | N | Y | Y | Y | Y | Y | Y | Y | 9 | 2 | 0 |
| Ford et al, 2020 | N | Y | N | Y | Y | Y | Y | Y | Y | Y | Y | 9 | 2 | 0 |
| Hashimi et al,2019 | N | Y | Y | N | Y | Y | Y | Y | Y | N | Y | 8 | 3 | 0 |
| Harder et al, 2012 | N | Y | Y | N | Y | Y | Y | Y | Y | N | Y | 8 | 3 | 0 |
| Lee et al, 2007 | N | N | Y | N | N | Y | Y | Y | Y | N | N | 5 | 6 | 0 |
| Pan et al, 2015 | N | Y | N | N | Y | Y | Y | Y | Y | N | N | 6 | 5 | 0 |
| Wang et al, 2020 | N | Y | N | N | Y | Y | Y | Y | Y | Y | Y | 8 | 3 | 0 |
| Sadja et al, 2013 | N | Y | N | N | Y | Y | Y | Y | Y | Y | N | 7 | 4 | 0 |
| Liu et al, 2020 | N | Y | Y | N | Y | Y | Y | Y | Y | Y | N | 8 | 3 | 0 |
| Espíndula et al,2017 | Y | Y | N | N | Y | Y | Y | Y | Y | Y | N | 8 | 3 | 0 |
| Carral et al, 2018 | Y | Y | N | N | Y | Y | Y | Y | Y | Y | Y | 9 | 2 | 0 |
| Zeng et al, 2014 | N | Y | N | N | Y | Y | Y | Y | Y | Y | Y | 8 | 3 | 0 |
| Wayne et al, 2017 | N | Y | N | N | Y | Y | Y | Y | Y | Y | Y | 8 | 3 | 0 |
| Zeng et al, 201935 | N | C | N | C | N | Y | Y | Y | Y | Y | Y | 6 | 3 | 2 |
| Liu et al, 2011 | N | C | N | N | Y | Y | Y | Y | Y | N | N | 5 | 5 | 1 |
| Pan et al, 2016 | N | Y | Y | N | N | Y | N | Y | Y | Y | N | 6 | 5 | 0 |
| Yan et al, 2013 | N | Y | Y | N | Y | Y | Y | Y | Y | Y | N | 8 | 3 | 0 |
| Zhang et al, 2015 | N | Y | N | Y | Y | Y | Y | Y | Y | Y | N | 8 | 3 | 0 |
| Wu et al, 2018 | N | Y | N | N | Y | Y | Y | Y | Y | N | N | 6 | 5 | 0 |
| Percentage of systematic reviews meeting each criteria | 11.5 | 80.8 | 42.3 | 11.5 | 88.5 | 100.0 | 96.2 | 100.0 | 100.0 | 69.2 | 46.2 | |||
Notes: AMSTAR items: Q1, a-priori design; Q2, duplicate study selection and data extraction; Q3, search comprehensiveness; Q4, status of publication (eg, non-English articles or dissertations); Q5, listing included and excluded studies; Q6, characteristics of the primary studies provided; Q7, scientific quality of the primary studies assessed and documented; Q8, scientific quality of the included data used appropriately in drawing conclusions; Q9, appropriateness of methods used to combine the findings of the primary studies; Q10, assessment of publication bias; and Q11, acknowledgement of conflicts of interest and potential sources of support in both the systematic review and the primary studies. Y, yes; N, no; C, cannot answer. We assigned 1 point to each “yes” item. The sub-column “Y”, the AMSTAR score, represents the quality of each included study which is the most important column in the table. The last row in the table indicates the percentage of included studies which met each item in AMSTAR scale. Bases on this, the methodological issues of included studies were identified.
PRISMA Statement Score/Point
| Topic | PRISMA Items | Luo | Lee et al, 2010 | Pan et al, 2015 | Yan | Zhang et al, 2012 | Buffart et al, 2012 | Cramer et al, 2012 | Dong et al, 2019 | Ford et al, 2020 | Hashimi et al, 2019 | Harder et al, 2012 | Lee et al, 2007 | Pan et al, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Title | 1 Title | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Abstract | 2 Structured | 1 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 |
| Introduction | 3 Rationale | 0.5 | 0.5 | 1 | 0.5 | 0.5 | 0.5 | 1 | 1 | 0.5 | 0.5 | 0.5 | 0.5 | 1 |
| 4 Objectives | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |
| Methods | 5 Protocol and | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 6 Eligibility criteria | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |
| 7 Information sources | 1 | 0.5 | 1 | 0.5 | 0.5 | 0.5 | 1 | 1 | 0.5 | 0.5 | 0.5 | 0.5 | 1 | |
| 8 Search | 0 | 0 | 0 | 0 | 0.5 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | |
| 9 Study selection | 1 | 0.5 | 1 | 0.5 | 1 | 0.5 | 1 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 1 | |
| 10 Data collection process | 0.5 | 0.5 | 1 | 0.5 | 1 | 0.5 | 0.5 | 1 | 1 | 0.5 | 0 | 0 | 1 | |
| 11 Data items | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |
| 12 Risk of bias in individual studies | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | |
| 13 Summary measures | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |
| 14 Synthesis of results | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |
| 15 Risk of bias across | 1 | 0.5 | 0.5 | 1 | 0.5 | 0.5 | 0.5 | 1 | 1 | 0.5 | 0 | 0 | 0.5 | |
| 16 Additional analyses | 1 | 0 | 0.5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Results | 17 Study selection | 1 | 1 | 1 | 0.5 | 1 | 1 | 1 | 0.5 | 1 | 0.5 | 1 | 0.5 | 1 |
| 18Study characteristics | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |
| 19 Risk of bias within | 1 | 0.5 | 0.5 | 0.5 | 0.5 | 0 | 1 | 1 | 1 | 0.5 | 0.5 | 0.5 | 0.5 | |
| 20 Results of individual studies | 1 | 1 | 1 | 1 | 1 | 0.5 | 1 | 1 | 1 | 1 | 0.5 | 0 | 1 | |
| 21Synthesis of results | 1 | 1 | 1 | 1 | 1 | 0.5 | 1 | 1 | 1 | 1 | 0.5 | 0 | 1 | |
| 22 Risk of bias across | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0 | 1 | 1 | 0.5 | 0.5 | 0.5 | 0 | 0.5 | |
| 23 Additional analysis | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Discussion | 24 Summary of evidence | 1 | 1 | 1 | 1 | 1 | 0.5 | 1 | 1 | 1 | 1 | 1 | 0.5 | 1 |
| 25 Limitations | 1 | 0.5 | 1 | 0.5 | 1 | 1 | 0.5 | 0.5 | 1 | 1 | 0.5 | 1 | 1 | |
| 26 Conclusions | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |
| Funding | 27 Funding | 1 | 0 | 0 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 0 |
| Title | 1 Title | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Abstract | 2 Structured summary | 0.5 | 0.5 | 0.5 | 0.5 | 1 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0 | 0.5 | 0.5 |
| Introduction | 3 Rationale | 1 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 1 | 1 | 1 | 0.5 | 1 |
| 4 Objectives | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |
| Methods | 5 Protocol and registration | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 6 Eligibility criteria | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |
| 7 Information sources | 0.5 | 1 | 1 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 1 | 0.5 | 0.5 | 1 | 1 | |
| 8 Search | 1 | 0.5 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0.5 | 0 | |
| 9 Study selection | 1 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 1 | 0 | 1 | 0 | 0.5 | 1 | 0.5 | |
| 10 Data collection process | 1 | 0 | 1 | 1 | 0.5 | 1 | 1 | 0.5 | 1 | 0 | 0.5 | 0.5 | 0.5 | |
| 11 Data items | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |
| 12 Risk of bias in individual Studies | 1 | 0.5 | 1 | 0.5 | 0.5 | 1 | 1 | 1 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | |
| 13 Summary measures | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |
| 14 Synthesis of results | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |
| 15 Risk of bias across | 0 | 1 | 0.5 | 1 | 1 | 1 | 1 | 1 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | |
| 16 Additional analyses | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Results | 17 Study selection | 1 | 1 | 1 | 1 | 1 | 0.5 | 1 | 0 | 1 | 0 | 1 | 1 | 0.5 |
| 18 Study characteristics | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |
| 19 Risk of bias within | 0.5 | 0.5 | 1 | 0.5 | 1 | 1 | 1 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0 | |
| 20 Results of individual studies | 1 | 0.5 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |
| 21 Synthesis of results | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |
| 22 Risk of bias across | 1 | 0.5 | 0.5 | 1 | 1 | 1 | 0.5 | 0.5 | 0 | 0.5 | 0.5 | 0.5 | 0 | |
| 23 Additional analysis | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Discussion | 24 Summary of evidence | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| 25 Limitations | 1 | 0.5 | 1 | 0.5 | 1 | 0.5 | 1 | 0.5 | 1 | 0.5 | 1 | 1 | 1 | |
| 26 Conclusions | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |
| Funding | 27 Funding | 1 | 0 | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 0 | 0 |
Notes: PRISMA statement from Liberati A, Altman D, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Journal of clinical epidemiology. 2009;62(10). Creative Commons.41